Asthma Treatment Market Insights, Competitive Landscape, and Forecast 2023-2030: Short-Acting Bronchodilators Dominate the $23.9 Billion Industry, Albuterol and Levalbuterol Lead in Treatments
July 25, 2024 07:18 ET
|
Research and Markets
Dublin, July 25, 2024 (GLOBE NEWSWIRE) -- The "Asthma Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The...
Asthma Market, Pipeline, and Competition Analysis Report, 2024: Features Insights on 90+ Companies and 100+ Pipeline Drugs, Including Dexpramipexole, TQC2731, and SHR-1703
April 11, 2024 11:18 ET
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Asthma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
Global Emphysema Treatment Market Report 2023: Sector to Reach $6.05 Billion by 2028 at a CAGR of 6.1%
March 13, 2023 11:53 ET
|
Research and Markets
Dublin, March 13, 2023 (GLOBE NEWSWIRE) -- The "Global Emphysema Treatment Market Size, Share & Industry Trends Analysis Report By Medication Type, By Distribution Channel, By Regional Outlook...
Global Asthma Drugs Market Forecast to 2028 - Opportunities with Commercialization of Biologics
June 21, 2022 05:38 ET
|
Research and Markets
Dublin, June 21, 2022 (GLOBE NEWSWIRE) -- The "Global Asthma Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Medications, Route of Administration, and Distribution Channels"...